ClearPoint Neuro (CLPT) Short-term Investments (2022 - 2023)

ClearPoint Neuro (CLPT) posted Short-term Investments of $9.9 million for Q1 2023, little changed sequentially from $9.9 million in Q4 2022.

ClearPoint Neuro (CLPT) Short-term Investments (2022 - 2023) Analysis & Trends

ClearPoint Neuro has reported Short-term Investments for 2 years, with the latest figure at $9.9 million in Q1 2023.

Quarterly Short-term Investments changed N/A year-over-year to $9.9 million in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $9.9 million (changed N/A YoY) and the FY2022 annual result came in at $9.9 million, changed N/A from the prior year.
Short-term Investments steadied at $9.9 million in Q1 2023 per CLPT's latest filing, from $9.9 million in the prior quarter.
Over five years, Short-term Investments peaked at $21.7 million in Q3 2022 and troughed at $9.9 million in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	ClearPoint Neuro	460.04 Mn	430.64 Mn	6.71 Mn

Download Data